$26.8 M

OVAS Mkt cap, 15-Oct-2018

$148 K

OvaScience Revenue Q2, 2018
OvaScience Gross profit (Q2, 2018)-18 K
OvaScience Gross profit margin (Q2, 2018), %(12.2%)
OvaScience Net income (Q2, 2018)-15.1 M
OvaScience EBIT (Q2, 2018)-15.5 M
OvaScience Cash, 30-Jun-201824.6 M

OvaScience Income Statement

Annual

USDFY, 2016

Revenue

653.0k

R&D expense

21.6m

General and administrative expense

49.2m

Operating expense total

70.9m

EBIT

(81.0m)

EBIT margin, %

(12406%)

Interest expense

659.0k

Interest income

659.0k

Pre tax profit

(82.1m)

Income tax expense

201.0k

Net Income

(82.3m)

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Revenue

15.0k30.0k75.0k146.0k189.0k197.0k63.0k67.0k148.0k

Cost of goods sold

112.0k166.0k

Gross profit

(45.0k)(18.0k)

Gross profit Margin, %

(67%)(12%)

R&D expense

4.5m5.3m5.7m4.0m4.0m6.0m6.0m5.0m5.8m2.6m5.0m

General and administrative expense

5.1m11.0m13.1m12.9m14.5m11.2m12.6m7.1m4.2m6.9m

Operating expense total

9.6m5.3m16.8m17.1m16.9m20.4m17.2m17.6m12.9m7.6m15.6m

EBIT

(9.6m)(12.4m)(16.8m)(17.2m)(17.8m)(21.4m)(18.2m)(19.0m)(14.6m)(7.6m)(15.5m)

EBIT margin, %

(112087%)(57247%)(23696%)(14684%)(9651%)(9626%)(23154%)(11316%)(10464%)

Interest expense

101.0k141.0k

Interest income

101.0k141.0k191.0k415.0k

Pre tax profit

(21.7m)(18.5m)(19.2m)(14.9m)(7.4m)(15.1m)

Income tax expense

75.0k50.0k92.0k9.0k

Net Income

(9.9m)(12.9m)(17.2m)(17.5m)(17.9m)(21.8m)(18.6m)(19.3m)(14.9m)(7.4m)(15.1m)

OvaScience Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

18.1m6.4m43.2m43.9m

Inventories

650.0k1.6m3.0m2.1m

Current Assets

45.1m61.9m129.9m116.4m

PP&E

880.0k3.4m8.3m5.6m

Total Assets

47.5m65.6m138.6m122.5m

Accounts Payable

1.7m2.5m3.4m2.2m

Current Liabilities

5.8m10.2m11.2m13.2m

Total Liabilities

14.3m

Additional Paid-in Capital

86.9m150.0m294.9m358.4m

Retained Earnings

(94.7m)(167.9m)(250.2m)

Total Equity

41.7m55.3m126.9m108.2m

Financial Leverage

1.1 x1.2 x1.1 x1.1 x

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Cash

16.6m12.1m134.7m70.2m50.8m20.5m95.9m50.5m25.4m19.7m24.6m

Current Assets

82.6m73.6m171.3m159.2m145.3m112.7m150.1m133.5m101.2m59.1m54.2m

PP&E

1.9m3.1m4.2m4.2m6.7m8.7m8.1m8.0m4.7m2.9m403.0k

Total Assets

85.8m77.5m175.8m164.5m152.8m122.1m158.7m142.4m106.3m63.0m55.5m

Accounts Payable

1.4m3.0m2.5m3.0m4.2m4.2m2.5m2.8m2.4m1.0m757.0k

Current Liabilities

7.1m8.8m6.6m7.6m9.9m11.8m10.7m11.3m10.6m5.0m4.7m

Total Liabilities

5.7m5.3m

Additional Paid-in Capital

141.6m144.4m281.0m286.2m289.9m298.5m354.8m357.4m360.1m366.2m366.7m

Retained Earnings

(75.8m)(111.9m)(129.4m)(147.3m)(189.7m)(208.2m)(227.5m)(265.4m)(308.8m)(316.6m)

Total Equity

78.7m68.6m169.1m156.7m142.6m108.8m146.6m129.9m94.7m57.3m50.2m

Financial Leverage

1.1 x1.1 x1 x1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x1.1 x

OvaScience Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(2.6m)(49.5m)(73.2m)(82.3m)

Depreciation and Amortization

450.0k1.3m2.2m

Accounts Payable

276.0k2.3m(171.0k)(1.2m)

Cash From Operating Activities

(1.6m)(30.6m)(50.3m)(61.7m)

Purchases of PP&E

(2.8m)(5.2m)(2.6m)

Cash From Investing Activities

(32.8m)(38.3m)8.3m

Cash From Financing Activities

6.1m51.7m125.4m54.1m

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(9.9m)(12.9m)(17.2m)(17.5m)(17.9m)(21.8m)(18.6m)(19.3m)(14.9m)(7.4m)(15.1m)

Depreciation and Amortization

330.0k506.0k

Accounts Payable

1.4m3.0m2.5m3.0m4.2m4.2m2.5m2.8m2.4m(1.4m)(1.5m)

Cash From Operating Activities

(8.9m)(13.8m)

Cash From Investing Activities

13.0m22.7m

OvaScience Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information